What Is PMS?
Premenstrual Syndrome (PMS) is a set of physical, emotional, and behavioral symptoms that occur cyclically during the luteal phase of the menstrual cycle (7 to 14 days before menstruation) and that resolve with the onset of menstrual flow.
Up to 80% of women of reproductive age experience some premenstrual symptom, but only 20-40% meet criteria for clinically significant PMS. The most severe form, Premenstrual Dysphoric Disorder (PMDD), affects 3-8% of women and is recognized as a distinct psychiatric entity in the DSM-5.
PMS is not an invented or exaggerated condition — it has a proven neurobiologic basis, involving the interaction between ovarian hormones and brain neurotransmitters. The impact on quality of life, relationships, and productivity can be substantial.
Neurobiologic Basis
PMS results from abnormal brain sensitivity to normal estrogen and progesterone fluctuations, affecting the serotonergic system.
Cyclical Pattern
Symptoms emerge in the luteal phase (post-ovulation) and resolve with menstruation. This cyclical pattern is an essential diagnostic criterion.
PMDD: Severe Form
Premenstrual dysphoric disorder affects 3-8% of women with severe emotional symptoms that significantly compromise functioning.
Pathophysiology
PMS pathophysiology does not involve abnormal ovarian hormone levels — estrogen and progesterone are normal. The central mechanism is an abnormal brain sensitivity to the physiological fluctuations of these hormones, particularly progesterone and its active metabolite, allopregnanolone.
Allopregnanolone is a neurosteroid that modulates GABA-A receptors in the brain, the main inhibitory system of the central nervous system. In women with PMS, the brain response to allopregnanolone is altered — instead of an anxiolytic effect, there may be a paradoxical anxiogenic effect, contributing to irritability, anxiety, and dysphoria.
The serotonergic system plays a central role. Fluctuations in estrogen and progesterone modulate the synthesis, release, and reuptake of serotonin. In the luteal phase, women with PMS show reduced serotonergic activity, which explains the efficacy of selective serotonin reuptake inhibitors (SSRIs) even in intermittent use.
Contributing factors include calcium and magnesium deficiency, alterations in the renin-angiotensin-aldosterone axis (water retention), and altered GABA sensitivity. Genetic predisposition is evident — twin studies demonstrate heritability of 30-50%.
Symptoms
More than 150 symptoms have been linked to PMS. Symptoms can be divided into emotional/behavioral and physical. The combination and intensity vary among women and may vary between cycles in the same woman.
Emotional and Behavioral Symptoms
- 01
Irritability and anger
Most frequent symptom, affecting up to 80% of women with PMS. A mismatch between stimulus and emotional response.
- 02
Anxiety and tension
Apprehension, nervousness, and muscle tension, frequently accompanied by insomnia.
- 03
Depressed mood
Sadness, tearfulness, and hopelessness. In PMDD, may reach clinically significant intensity.
- 04
Difficulty concentrating
Reduced attention, "mental fog", and lower cognitive productivity during the luteal phase.
- 05
Food cravings
Intense cravings for carbohydrates and sweets, possibly tied to the brain's attempt to raise serotonin.
- 06
Social isolation
Tendency to avoid social interactions and feeling overwhelmed by daily demands.
Physical Symptoms
- 01
Mastalgia (breast pain)
Bilateral breast engorgement and tenderness, tied to water retention and progesterone effects.
- 02
Abdominal distension and edema
Abdominal bloating and edema of extremities from sodium and water retention mediated by aldosterone.
- 03
Headache
May be tension-type or migrainous, tied to hormonal fluctuations, especially estrogen drops.
- 04
Fatigue
Fatigue disproportionate to effort, frequently tied to luteal-phase sleep disturbances.
- 05
Muscle and joint pain
Diffuse myalgia and arthralgia, possibly mediated by prostaglandins and mild inflammatory changes.
Diagnosis
PMS diagnosis is clinical and requires prospective documentation of the cyclical symptom pattern. No laboratory test confirms the diagnosis. Hormonal measurements are normal and not indicated.
The essential criterion is the temporal restriction: symptoms must be present in the luteal phase, absent in the follicular phase (days 4-12 of the cycle), and cause functional impairment. At least 5 symptom-free days after menstruation are required to differentiate PMS from chronic disorders.
🏥ACOG Diagnostic Criteria for PMS
- 1.At least 1 clinically significant emotional or physical symptom in the 5 days before menstruation
- 2.Symptoms present in at least 3 consecutive cycles (prospective documentation)
- 3.Symptom relief within 4 days after menstruation begins
- 4.At least 5 symptom-free days in the follicular phase
- 5.Identifiable functional impairment (social, professional, relational)
- 6.Not attributable to another psychiatric or medical condition
DIAGNÓSTICO DIFERENCIAL
Differential Diagnosis
Premenstrual Dysphoric Disorder
Read more →- Severe psychiatric symptoms (depressed mood, severe anxiety)
- Significant functional dysfunction at work and in relationships
- Cycles documented with PRISM or DRSP
- Suicidal ideation
Testes Diagnósticos
- Prospective symptom diary for 2 cycles (DRSP)
- Psychiatric evaluation
Adjunctive to pharmacologic treatment (SSRIs) for PMDD; contributes to anxiety reduction and mood regulation
Depression
Read more →- Depressive symptoms not exclusively premenstrual
- Also present in the follicular phase
- Elevated scores on depression scales (PHQ-9)
- Suicidal ideation
- Severe dysfunction
Testes Diagnósticos
- Symptom diary
- PHQ-9
- Psychiatric evaluation
Moderate evidence for reducing depressive symptoms; adjunctive to psychotherapy and pharmacotherapy
Generalized Anxiety
Read more →- Persistent anxiety not related to the cycle
- Generalized and non-cyclical worry
- Physical symptoms of tension outside the luteal phase
Testes Diagnósticos
- GAD-7
- Symptom diary for 2 cycles
Strong evidence for anxiety reduction through HPA axis regulation and endorphin release
Hypothyroidism
Read more →- Fatigue, weight gain, constipation
- Cold intolerance
- Symptoms not exclusively premenstrual
Testes Diagnósticos
- TSH and free T4
Adjunctive to hormonal treatment; does not replace levothyroxine
Endometriosis
Read more →- Progressive dysmenorrhea
- Chronic pelvic pain not only premenstrual
- Deep dyspareunia
- Associated infertility
Testes Diagnósticos
- Transvaginal ultrasound
- Pelvic MRI
Modulation of central sensitization and chronic pain as part of multimodal management
Premenstrual Dysphoric Disorder (PMDD)
PMDD is the severe form of PMS, recognized as a diagnostic entity in the DSM-5. Psychiatric symptoms are predominant and severe — marked depressed mood, intense dysphoria, elevated anxiety — and cause significant functional dysfunction at work, in relationships, and in daily activities. It affects 3-8% of women of reproductive age.
Differential diagnosis is fundamental because PMDD requires specific pharmacologic treatment (SSRIs, particularly paroxetine and sertraline during the luteal phase). Acupuncture may be incorporated as an adjunct, contributing to mood regulation and anxiety reduction, but does not replace pharmacotherapy in severe PMDD.
Depression and Generalized Anxiety
Differentiating PMS from primary mood disorders rests on symptom timing. In PMS and PMDD, symptoms are strictly cyclical — they emerge in the luteal phase and disappear once menstruation begins. In depression and generalized anxiety, symptoms are present across all phases of the cycle and may intensify premenstrually.
The reference diagnostic instrument is a prospective symptom diary (DRSP or PRISM) over at least 2 cycles. Absence of a symptom-free period in the follicular phase rules out PMS/PMDD and suggests an underlying mood disorder that requires specific psychiatric evaluation.
Hypothyroidism
Hypothyroidism may cause symptoms that resemble PMS — fatigue, weight gain, irritability, sleep disturbances, and depression. Clinical differentiation rests on the absence of the typical cyclical pattern: in hypothyroidism, these symptoms persist throughout the entire menstrual cycle, not exclusively premenstrually.
TSH measurement should be part of the basic workup for any woman with premenstrual symptoms, especially when fatigue and weight gain are prominent. Adequate treatment of hypothyroidism frequently resolves symptoms without specific PMS intervention.
Treatment
PMS treatment follows a stepwise approach, starting with lifestyle modifications and progressing to pharmacotherapy according to severity. For PMDD, SSRIs are the first-line treatment with proven efficacy.
Lifestyle Modifications
Regular aerobic exercise (30-60 min, 3-5x/week), reduced caffeine, alcohol, and sodium, and a diet rich in complex carbohydrates. Calcium (1,200 mg/day) is the supplement with the best evidence.
Supplementation
Calcium (1,200 mg/day — 50% reduction in global symptoms), magnesium (200-360 mg/day), vitamin B6 (50-100 mg/day), vitex agnus-castus (20-40 mg/day). Moderate evidence for all.
SSRIs (First Line for PMDD)
Fluoxetine (20 mg), sertraline (50-150 mg), escitalopram (10-20 mg). May be used continuously or only in the luteal phase (intermittent use). Effective in 60-70% of PMDD cases.
Hormonal Contraceptives
Drospirenone + ethinylestradiol on a 24/4 regimen (approved for PMDD). Suppress ovulation and hormonal fluctuations. Alternative when SSRIs are not tolerated or desired.
Acupuncture as Treatment
Acupuncture is investigated as a complementary therapy for PMS, with preliminary studies suggesting possible benefit for physical and emotional symptoms. Proposed mechanisms — still under investigation — include possible modulation of neurotransmitter systems (serotonin, GABA) and autonomic tone, alongside endogenous-opioid effects. There is no firm evidence that acupuncture alters hormone levels; it does not replace SSRIs or contraceptives when indicated.
Systematic reviews and meta-analyses suggest reduction of overall PMS symptoms compared with control, with variable effect magnitude across studies and heterogeneous methodological quality. The reported benefit covers both physical symptoms (mastalgia, distension) and emotional symptoms (irritability, anxiety), but the robustness of this evidence is still limited.
Acupuncture may be especially valuable for women who prefer to avoid medication, have contraindications to SSRIs or contraceptives, or wish to complement pharmacologic treatment. Typical protocols involve weekly sessions with intensification in the premenstrual week, for 3-4 consecutive cycles.
Prognosis
PMS is a chronic condition that persists as long as ovulatory menstrual cycles continue. Symptoms typically cease with menopause, pregnancy, and during use of medications that suppress ovulation.
With adequate treatment, most women achieve significant improvement in quality of life. SSRIs are effective in 60-70% of PMDD cases, and combined approaches can benefit up to 80-90% of patients.
It is important to recognize that PMS may be a risk factor for depression in perimenopause and the postpartum period. Women with PMDD should be monitored across hormonal transitions for early detection of mood disorders.
Myths and Facts
Myth vs. Fact
PMS is silliness or exaggeration
PMS and PMDD are medical conditions with a proven neurobiologic basis. PMDD is classified as a psychiatric disorder in the DSM-5. Symptoms result from the interaction between ovarian hormones and brain neurotransmitters.
All women have PMS the same way
Intensity varies enormously. While mild symptoms are common, only 20-40% meet clinical criteria. Severity is determined by individual brain sensitivity to hormonal fluctuations.
Chocolate cures PMS
Sweet cravings may reflect the brain's attempt to raise serotonin via tryptophan. Although they bring momentary relief, they don't treat the cause. Calcium and exercise have much more robust evidence.
PMS hormones are "out of control"
Hormone levels in PMS are normal. The problem is abnormal brain sensitivity to physiologic fluctuations, mediated by altered GABA and serotonin receptors.
When to Seek Help
If premenstrual symptoms interfere with work, relationships, or quality of life, seek medical evaluation. Effective treatments are available and can transform the menstrual experience.
Frequently Asked Questions
PMS is a set of physical, emotional, and behavioral symptoms that occur cyclically in the luteal phase of the menstrual cycle (7-10 days before menstruation) and end when bleeding begins. The most common are irritability, breast tenderness, water retention, fatigue, anxiety, and mood changes.
Proposed mechanisms — still under investigation — involve possible modulation of neurotransmitter systems (serotonin, GABA) that influence mood and sleep, effects on autonomic tone, and endogenous opioid release. There is no evidence that acupuncture alters estrogen and progesterone levels. In PMS, it is adjunctive — it may help reduce irritability, anxiety, breast tenderness, and pain — and does not replace SSRIs or contraceptives when indicated by the gynecologist.
The usual protocol involves luteal-phase sessions (7-14 days before menstruation), 2 to 3 times per week, for 3 to 4 consecutive cycles to assess response. Preventive acupuncture — started before symptoms peak — is more effective than treatment started after PMS is already established.
Yes. PMS causes moderate symptoms that affect well-being but do not impair functioning. PMDD is the severe form, with dominant psychiatric symptoms (intense depressed mood, severe anxiety) that cause significant dysfunction at work and in relationships. PMDD affects 3-8% of women and generally requires pharmacotherapy with SSRIs in addition to acupuncture.
There is preliminary evidence. Systematic reviews and meta-analyses in peer-reviewed journals suggest acupuncture may be superior to control in reducing PMS symptoms, with variable effect magnitude and heterogeneous methodological quality across primary studies. Sham comparisons and limited samples restrict the strength of conclusions; the literature points to possible benefit as adjunctive therapy, not as a substitute for first-line interventions (SSRIs, contraceptives) when indicated.
The definitive criterion is timing: in PMS, symptoms emerge in the luteal phase and disappear in the first days of menstruation. If symptoms persist across all phases of the cycle, a primary mood disorder (depression, anxiety) is intensifying premenstrually. A prospective symptom diary over 2 cycles is the reference instrument.
Yes, some have evidence. Vitamin B6 (50-100 mg/day), magnesium (360 mg/day in the second half of the cycle), and chasteberry (Vitex agnus-castus) have clinical studies for PMS. Omega-3 and calcium have also shown benefit in reviews. These supplements can complement acupuncture and lifestyle changes.
It can vary. Some women report progressive worsening across the reproductive years, especially in perimenopause. Others note improvement. Variability is large. A history of depression, anxiety, and stressful life events raises the risk of more severe PMS. Menopause, in general, resolves PMS.
Yes, significantly. Regular aerobic exercise — 30 minutes per day, 5 times per week — reduces PMS symptoms by raising endorphin production, lowering cortisol, and regulating the autonomic nervous system — the same mechanisms acupuncture acts through. Regular exercise combined with acupuncture is synergistic.
The gynecologist is the reference physician for PMS. For cases with significant psychiatric components, psychiatric evaluation may be necessary. The physician acupuncturist can integrate care as a complement for managing physical and emotional symptoms, especially for women who prefer non-pharmacologic approaches.
Related Reading
Deepen your knowledge with related articles